Showing posts with label Personnel. Show all posts
Showing posts with label Personnel. Show all posts

Monday, April 15, 2013

“Madagascar en deuil”


Ref.:   “Madagascar en deuil” [French]
From: Ralaivao-Mano S, Antananarivo, Madagascar


Bonjour à tous!

Suite à un paludisme grave (neuro-paludisme), nous avons le regret de vous affirmer que Dr NORO de la Fondation Raoul Follereau qui était avec nous lors de la formation à Bamako en février 2012, est décédé aujourd'hui le 08 juin 2012.
Prier pour elle, que son âme soit avec notre DIEU.

Dr Samuel RALAIVAO-MANO
Médecin au Service de Lutte contre la Lèpre
Responsable de suivi et évaluation
BP: 8669
ANTANANARIVO 101
MADAGASCAR



Dear All,

Following severe (cerebral) malaria, we regret to say that Dr. Noro from the Raoul Follereau Foundation, died on June 8th, 2012.
Pray for her, that her soul is with our God.

Dr.
Samuel RALAIVAO-MANO 

Tuesday, April 10, 2012

"On service training in leprosy” in Mato Grosso and Mato Grosso do Sul, Brazil.


Leprosy Mailing List – March 8th, 2012 
Ref.:    "On service training in leprosy” in Mato Grosso and Mato Grosso do Sul, Brazil.
From:  J Barreto, S. Paulo, Brazil

Dear Salvatore,
Thank you in advance for sharing this experience of mine about << "on service training in leprosy" >> with the leprosy mailing list readers.
Since 2007, the German leprosy relief association (DAHW) and the Instituto Lauro the Souza Lima (ILSL) have adopted the methodology of "on service training in leprosy", in the states of Mato Grosso and Mato Grosso do Sul in Brazil.  The method consists of 3 steps:
First: evaluation of the previous knowledge about leprosy.
Second: a lecture, with explanation of what is, indeed, leprosy, i.e., its epidemiology, microbiology, classifications (Madrid, R&J, WHO), clinical diagnosis, laboratorial findings and differential diagnosis, management of the disease and its reactions, and prevention of incapacities.
Third: supervised practice, with recently diagnosed patients, with sensitivity tests (thermal, pain and tactile), palpation of nerve trunks, collection of skin smears and staining of slides "in loco", and evaluation of their household contacts.
Results of the last year (2011):
Number of "on service trainings": 13.
Number of municipalities which participated: 79. 
Number of health professionals trained: 1031, and among them 261 were physicians.
Number of patients evaluated: 588, and among them 123 (almost 20%) new cases were diagnosed.
The complete results of each work can be seen in the site www.dahwmt.org.br.  Finally, the amount of money which was spent to achievement of this results: less than U$ 70.000,00. 
And I think to myself: what could we do with U$ 1 million?
Regards,
Jaison

Tuesday, December 27, 2011

Commemoration of the Civil Servant Day in Brazil. FIOCRUZ initiative to honor its workers


Leprosy Mailing List – December 5th, 2011
Ref.:    Commemoration of the Civil Servant Day in Brazil. FIOCRUZ initiative to honor its workers.From: P A M Schreuder, Maastricht, The Netherlands

Maastricht, 30-10-2011
José Augusto da Costa Nery, MD, PhD - Professor of Dermatology, University Gama Filho, FIOCRUZ and Santa Casa, Rio de Janeiro
José Augusto was born and studied medicine in Belém, Pará, Brazil.  In 1982, he came to Rio de Janeiro to do a 2-years post-graduate course in dermatology.  He always was interested in the public health side of dermatology and became involved through Prof. Dr. Maria Leide W. de Oliveira in the Hanseníasis programme of Caxias, Rio de Janeiro.  When Dr. Maria Leide became National Hanseníasis Coordinator at the Ministry of Health of Brazil in 1986, she invited Prof. Dr. Euzenir Sarno to set up a Leprosy National Referral Centre at FIOCRUZ (Fundação Oswaldo Cruz, Rio de Janeiro, Brazil) and to start research in Hanseníasis.  José Augusto was then invited to help to re-start and give new life to the Hanseníasis Outpatient Department of FIOCRUZ.  He has many scientific publications to his name.
José Augusto is one of the few dermatologists interested in public health, and his two main areas of interest are Hanseníasis (FIOCRUZ and Santa Casa) and Sexual Transmitted Diseases (Santa Casa).  He must be one of the very few dermatologists who do not have a private practice.  He is Professor of Dermatology, University Gama Filho and supervises residents in dermatology and medical students at FIOCRUZ and Santa Casa.  He is a very dedicated Doctor to his patients and an excellent and compassionate teacher, and has a very gentle personality. 
With great respect we would like to praise this initiative of FIOCRUZ, an international well-known research Centre in many fields of medicine, to honor its workers.  We, readers of LML, we are very pleased to extend our congratulations to José Augusto.
Ben Naafs
Salvatore Noto
Pieter AM Schreuder

Wednesday, June 22, 2011

Leprosy supervisors will be conducting dermatology clinic in rural areas

Leprosy Mailing List – May 7th, 2011 
Ref:     Leprosy supervisors will be conducting dermatology clinic in rural areas
From: J Mukalay, Kinshasa, Democratic Republic of Congo

Dear Salvatore,
I refer to prof. Ryan’s message (LML May 5th, 2011).  The “Task Force for Skin Care for All” sounds very interesting to us today when leprosy is becoming less endemic and less motivation of field workers.
We have already planned a dermatology workshop for some key leprosy supervisors nurses who will be conducting dermatology clinic in rural areas.
How to get the CD? Any cost?
With regards,
Jean Mukalay
Mr. Jean Mukalay
Technical advisor for The Leprosy Mission Congo
Kinshasa
Democratic Republic of Congo

Friday, January 21, 2011

Leprosy in the teaching curricula

Leprosy Mailing List – December 31st, 2010

Ref.:   Leprosy in the teaching curricula
From:  Ryan T., Oxford, UK


Dear Salvatore,

Pran's dagger goes straight to the heart (LML Dec. 18th, 2010).  Unfortunately Dermatology gets too little space in the Oxford curriculum.  All medical students attending for a short course see first of all a large (updated by myself) poster on Leprosy and that is all.  That is why I emphasise the elective period when visits to India, S America, and Nepal attract them to look for a subject to study and none better than leprosy.  I invite students to accompany me on my regular trips to India.

Getting Leprosy into the general curriculum, sadly, is unlikely to compete with all the very common problems they must be expert on when they become family practitioners in the UK.  They will not see leprosy in Oxford clinics.  If in India and Nepal for example those centres regularly accepting students were to upgrade the teaching so leprosy was seen as part of Dermatology and at the same time financial help with travel was facilitated then we might recruit future leaders of the field.

I am directing my energies in that direction but will copy Pran's mail to those who plan the Oxford curriculum.

Terence


Nippon Foundation stops funding WHO initiative on surveillance of drug resistance in leprosy

Leprosy Mailing List – December 31st, 2010
Ref.:   Nippon Foundation stops funding WHO initiative on surveillance of drug resistance in leprosy 
From: Narasimha Rao P., Hyderabad, India



Dear Salvatore,
The message from Dr Pannikar (LML 5th Dec. 2010) informing about Nippon foundation deciding not to continue to fund the WHO initiative on surveillance of drug resistance in leprosy (which I gathered form the correspondence on this issue) is definitely a set back in fight against leprosy.  But it would be relevant to analyze the reasons for such a decision by the very consistent and generous funding agency.

Only reason I can think of immediately is the shrinking numbers of leprosy being reported widely all over the world, especially India.  As any programme donor or manager takes in to consideration the number of beneficiaries, (which is the number of patients in this case / prevalence rate), the less numbers of leprosy patients projected  in world leprosy statistics, makes it less attractive to fund the programme.

However, there are good numbers of missing leprosy patients from NLEP/govt of India registers, which influence world leprosy figures greatly.  It is a fact that numbers of leprosy reported from India by government/NGO leprosy agencies do not take into consideration a significant group of leprosy patients seen and treated by Dermatologists all over India as these patients are not enrolled/registered  in government/NLEP registers.  And there are more than 9,000 actively practicing dermatologist all over India as of now.
Just to estimate on how big this missing number could be,…I have  conducted a email questionnaire, in year 2007, on how may leprosy patients a popular dermatologist sees per year.  E-mails were sent to about 120 dermatologists all over India.  Responses were obtained for the request from 26 Dermatologists all over India in a 4-week period. The 26 responders were from 7 different states (Andhra Pradesh, Tamil Nadu, Karnataka, West Bengal, Gujarat, Rajasthan and New Delhi).  Of these 10 Dermatologists have, both hospital practice and private practice.  Only one of the responders had a full time hospital attachment.  Rest of the 15 were full time private practitioners.  The approximate number of leprosy patients seen by 26 Dermatologists in one year is given in the table below:

At hospitals
At clinics
Total
Average
New patients
1169
466
1635
62.8
Partially treated patients
464
95
559
21.5
Old patients with disabilities
226
117
343
13.1

The average number of new leprosy patients seen by Dermatologists under study per year was 62.  This is a approximate figure.  Considering that only 6000 (of 9000) dermatologists are in private practice, even if we consider 10 new leprosy cases per dermatologist per year, the number would be 60,000 unregistered cases.  This could be a conservative estimate.  In an endemic areas the numbers could be more as patients going to primary care physician and other specialists (neurologist orthopedician) are not taken into consideration at all.  

Significance of these observations: Although the number of Dermatologists included in this study does not meet the sample size requirements, the results of the study cannot be ignored.  The direct result of these missing numbers could  be...
  1. Inability for the Government and leprosy agencies to assess the exact number of leprosy patient load in a community, which leads to improper planning and budgeting for leprosy;
  2. which could lead to an inadequate availability of resources (men and material and even MDT blister packs) where and when required;
  3. finally, it leads to improper planning and inability to convince and attract donors about the seriousness of the requirements and problem of leprosy.  
I being a dermatologist my self and involved in leprosy, can vouch that most dermatologists can diagnose leprosy and administer WHO MDT very well and correctly.  But I am not sure that they are very good managers of reactions of leprosy, nerve damage and its prevention, ulcer care or management of disabilities of leprosy. Hence, there continues to be a need for an agency or programme to manage these requirements which I presume only NLEP or WHO leprosy programme is capable of.  With funds drying up, as reported by Dr Pannikar, I foresee a very bleak future for care of leprosy patient’s problems in near future, even from these agencies.  

I also take this opportunity to appeal to all who matter, not to emphasize on bringing down the numbers of leprosy and equate it to success of the programme; which I am sure has resulted in migration of so many patients to private dermatologists for the want of care and therapy.

With best regards,

P. Narasimha Rao MD., PhD.


Loss of clinical expertise in leprosy in Africa

Leprosy Mailing List – December 18th, 2010

Ref.:   Loss of clinical expertise in leprosy in Africa.
From: Noto S., Genoa, Italy



Dear Dr Pannikar,

Thank you very much for your important contribution to the LML dated Dec. 5th, 2010.  I would like adding my comment on your second issue, the one about the “the rapid loss of expertise in leprosy at all levels”.  Particularly I refer to the African Region and to the loss in clinical expertise only.

In the last years there has been loss of clinical expertise in leprosy.  The situation is complex.  On one side there still are good leprosy doctors in Africa and I regularly meet excellent leprologists there; on the other side the service offered to the patient is getting poorer.  The matter has evolved in such a way that even when good leprologists are involved in leprosy control activities their clinical knowledge is frustrated. 

Leprosy control activities are mostly oriented to the delivery of multi-drug therapy (MDT) but, MDT is only part of the correct patient’s management.  Actually the most important aspect of the job is the patient, not the delivery of MDT.  That is why clinical expertise is “cardinal”.   

There is lack of clinical leprosy teaching at different levels: - peripheral health clinic, leprosy programme, medical and paramedical schools.  Herewith I briefly comment about the first two levels only.

Clinical expertise is based on “bedside teaching”, i.e. where the patient is, at the health clinic.  Here all three involved actors have to be present together, namely: - patient, local health staff and leprosy control staff.  They all learn and teach from and to each other.  I underline that local and leprosy staff learn from the patient.  The correct evolving of this process ensures creation and improvement of clinical expertise and higher quality of the service delivered.

Unfortunately in the last years I have seen that leprosy staff do not assess patients and, local staff do it by themselves when the leprosy staff is not present.  The consequences are that they loose opportunity for improvement in clinical knowledge and the quality of the service decreases.

Best regards,

S. Noto

Priorities for future of leprosy control: communication by Professor T Ryan

Leprosy Mailing List – December 18th, 2010

Ref.:   Priorities for future of leprosy control: communication by Professor T Ryan (LML Dec 16th, 2010)
From: Das P K, Amsterdam, the Netherlands 


Dear Salvatore,

The observation of widely present dis-interest of medical students on leprosy is understandable, because leprosy (the disease both as a matter of scientific and clinical subject) is more or less neglected or overlooked by the professors in Dermatology, Plastic surgery, Opthalmology, Orthopaedics as a whole probably with some rare exception.  Even when it comes up, as a matter of discussions, there is hardly anyone to be heard, saying that the dynamics of leprosy pathology is intriguing for exploring the dynamics of host, immune responses.

Similarly, in clinics, Dermatologists can go on highlighting the comparative aspects of other dermatological diseases like psoriasis, atopic dermatitis, wounds, depigmintation with leprosy spectrum.  Microbiologically, one can teach the students comparative aspects of mycobacteria as a whole and the disease causing mycobacterioses i.e tuberculosis and leprosy.

In another words, leprosy should be included in full vigour in total curricula of medical science and should not be left isolated, as a kind of special subject, like charitable diseases.  It is high time for the wise community to accept leprosy within the whole curricula of medicine specialising in history of medicine,  immunology, pathology, neurology, dermatology, opthalmology, micro surgery etc not only in places where leprosy is prevalent, also in the global region where leprosy is almost non existent.

May be, it will be good idea that Professor Ryan will be kind enough to take the initiative starting with Oxford, to introduce leprosy in the teaching curricula.

Pran

Priorities for future of leprosy control

Leprosy Mailing List – December 18th, 2010

Ref.:   Priorities for future of leprosy control
From: Samy A. Antony, Mumbai, India 



Dear Dr. Noto,

This has reference to Dr. Pannikar’s (Leprosy Mailing List dated 5 December 2010) concern on the priorities for future leprosy control and we fully endorse his views expressed.

In the present scenario of increasing trend in new case registration at different geographical locations in India, decreased political commitment and scarce funds will result in a situation that may warrant greater resources and deployment of trained manpower in the near future.  Therefore, sustaining leprosy control work with adequate resources and requisite expertise merits urgent attention.

Further, the emphasis today also should be on developing a common strategy for India based on an authentic assessment of the leprosy situation. The present context of integration calls for special interventions planned, taking into consideration the regional variations in the disease burden. A specific common plan of action and adequate resources must be part of it with a firm commitment as it was in the past.

We firmly believe that the ILEP agencies working in India have greater potential to draw on from the rich experience of the past decade and help evolve a national plan on the priority areas of leprosy control.  We suggest a joint consultation to bring forth this agenda at the national level in collaboration with the government and leprosy NGOs to make a long-term impact.

With kind regards,

A. Antony Samy
Chief Executive

ALERT - INDIA (Association for Leprosy Education, Rehabilitation and Treatment - India)
B-9, Mira Mansion, Sion (West), Mumbai – 400 022, India.
Tel: +91-22-24033081 / 2; Fax: +91-22- 24017652; Email: alert(at)bom5.vsnl.net.in

Priorities for leprosy control

Leprosy Mailing List – December 16th, 2010

Ref.:   Priorities for leprosy control
From: Ryan T., Oxford, UK


Dear Salvatore,

It is the loss of interest and of experts that is most worrying.  The doctor in training is now unlikely to see a patient with leprosy, hear a lecture on this topic or read a text. When fully qualified many other topics will have fired an interest.  As ever the student elective catches him or her at the most receptive and not yet firmly on route to other branches of Medicine.

I would like more centres that still have many patients to continue to welcome medical students, and funding is set aside for travel scholarships.  The relevance of what they see there will be reduced if all they see is leprosy.  What they need to experience is how leprosy fits into professions they may take up such as Dermatology, Plastic surgery, Ophthalmology, Orthopaedics.  I therefore suggest that we build up a few places for study where these branches of medicine are also taught and there are enough affected persons as in India or Brazil and where the enthusiasm for leprosy by practitioners of these professions is infectious.

Terence Ryan
Emeritus Professor of Dermatology, Oxford University

Priorities for future of leprosy control

Leprosy Mailing List – December 11th, 2010

Ref.:   Priorities for future of leprosy control
From: Revankar C R, New Delhi, India


Dear Dr Noto,

This has reference to LML December, 5th, 2010 on Priorities for future of leprosy control by Dr. V. Pannikar.  I thought of writing my personal views on this important topic.  I agree with the views expressed by Dr. Pannikar.

Having reached a major mile stone in reducing the total number of cases and curing a large number of patients, we all are facing a major challenge of mobilizing resources to address several post leprosy elimination issues such as continued disease transmission, drug resistance, reactions and nerve damage, disability prevention and care, social stigma, human rights sustaining leprosy control services and political support etc.

Several other competing diseases of public health importance with high morbidity and mortality rates such as malaria, TB, HIV etc and Millennium Development Goals (MDG) 2015, one would expect that funding for leprosy and other neglected tropical diseases might not be available as we expect both from the governments and external agencies.  Along with this, available expertise (old & young) also started diverting to adequately funded health programmes/projects.

In this current scenario, we may have to :-
(1)
mobilize funding from other than leprosy agencies;
(2)
develop integrated approaches along with other programmes wherever possible (eg. integrated neglected tropical diseases control; TB/Leprosy combined activities; leprosy drug resistance studies with antimicrobial resistance studies; linking ocular leprosy problems leading to impaired vision to "Vision 2020" programme, disability care into CBR etc).

Wishing you all a Happy New Year!

Regards,

C R Revankar

New Delhi

The letter of Dr Pannikar

Leprosy Mailing List – December 11th, 2010

Ref.:   The letter of Dr Pannikar
From: Porichha D., Bhubaneswar, Orissa, India


Dear Noto,

The letter regarding drug sensitivity testing (DST) for surveillance and loss of expertise by Dr V Pannikar (LML Dec. 5th, 2010), an eminent contributor to the programme is timely.  While appreciating for this reminder, I would like to float the following stray thoughts.
1.                     
Some articles expressing concern about retaining of expertise and drying of fund for leprosy work appeared in leading journals.  In the integrated system for expertise there is need to look at the districts hospitals and medical colleges as per recent WHO guidelines.  This needs strengthening the chain of referral systems.  In certain state as Orissa, India, there is a district nucleus medical officer to facilitate services to the cases referred from the periphery.  An apex team consisting of orthopaedic surgeon and an ophthalmologist in addition to a dermatologist attends to higher order services.
2.
Other sources of expertise are Associations of Leprologists (this has membership from all age groups).  It is hoped that some of the endemic countries as Brazil are also having similar professional bodies.  Their members, though some time critical about the WHO strategy, have assisted the programme whenever they are asked for.  These bodies have members from other specialties, leprosy needs in addition to dermatologists.  No other disease probably has such rich expertise.  I feel, if leprosy is to be viewed as any other disease,  programme  need to be content with the support of these groups.
3.
Regarding resources, any country where leprosy control is a national programme, it has its separate budget.  There is also some provision in the state budget.  There should not be problem to divert fund to organize a surveillance unit at the state level as priority.  DST can be undertaken in pioneer leprosy institutes, as already done in India.  Side by side, trend in new cases detection and its relation other indicators need to be analyzed to know the impact of 30 years MDT.  Alternatively leprosy should be integrated in Integrated Disease Surveillance Programme.
4.
The ILEP and other International Agencies patronizing leprosy in terms of expertise and resources are still with us to support if the needs as surveillance are prioritized.
5.
Finally research has to be integrated in related departments in teaching and other pioneer institutions.

Yours Sincerely,

D Porichha
Medical Coordinator, LEPRA Society, Bhubaneswar

The Downfall of Leprosy Expertise (to pauperism)

Leprosy Mailing List – December 9th, 2010

Ref.:   The Downfall of Leprosy Expertise (to pauperism)’
From: Both P., Apeldoorn, The Netherlands



Dear Salvatore,

Dr V. Pannikar described this so well, in his 5th of December LML contribution. Earlier I was thinking that leprosy expertise was at risk to dwindle, to fade away (with the old heroes/soldiers in leprosy!).  It seems to plummet.

Dr Francesca Gajeta in her entry of 8 December expresses her hope that ILEP [*] could look into this.  And ILEP has done that, tried to do that, and the ILEP bureau is in the best position to update LML [*] readers about that, for example about the proposal to develop an Advanced Course on Leprosy.

Apart from that we should not forget the important initiative of WHO and NLR [*] (and GLRA? [*]) to develop a Training Needs Analysis (TNA) and Capacity Building plan. This stands next to the Enhanced Global Strategy for Further Reducing the Disease Burden Due to Leprosy (2011 – 2015).  The effect of this will be seen, we hope, in the following years.  The authors of this TNA and Capacity Building plan are in the best position to keep us informed.

The Leprosy Mission International has considered the issue of the ‘downfall’ too.  We have done a training review among leaders of programmes we are supporting.  We concluded that the recommendation seems to be to focus more on training in-country than in international institutions.  I hope that this conclusion does not come across as that TLM [*] would like to do away with international training institutions.  The future of such international training in leprosy would need a careful consideration among all stakeholders involved.  From that training review we have developed a ‘Position paper on Preserving Leprosy Expertise through TLM Programmes’.  At the same time in each country supported by TLM we have asked the TLM country team to do strategic planning (as and for TLM input and impact) and to develop a capacity building plan from that or because of that.  In other words, as TLM, we are taking this issue seriously.

I believe many more ILEP members and others are concerned and have their thoughts and have planned actions related to the dwindling leprosy expertise.  If they haven’t yet, it is time to listen to the alarm bells.  We have raised the issue repeatedly during ILEP meetings, for example whether ILEP could find a way to monitor the capacity in relation to leprosy ‘world-wide’.  (And I suppose that the TNA may contribute to getting some idea about that worldwide capacity, if the outcome of National TNA’s would be put together and be repeated at intervals.  I do not think there are plans to do so.)
   
I have been reading the history of The Leprosy Mission recently.  At an International TLM Conference in 1953 someone considered the need in leprosy so great ‘as to be beyond the power of all the Churches combined to meet it, even if they had no other object of their compassion and service.’  And, at that same meeting the Medical Committee called ‘the attention of the authorities to the need in each endemic area of an appropriate representative body to plan, develop, and co-ordinate the work. … Governments should be represented on this body at the highest level …Only when government, missions, and other voluntary organisations, the community and the leprosy patients themselves recognize each their own responsibility …’

Leprosy expertise need to be maintained. The last patient has the same right as the first patient or as the millions recovered from the illness and consequences of leprosy. But what expertise, where and who (Persons affected - Leprologists – PHC [*] workers – Dermatologists and other specialists – community members - ….)? How many and how many of each in different places/countries? What (how much knowledge among different cadres; how much and what kind of knowledge and expertise)? When? And especially also ‘why’, to what purpose (‘eradication’, ‘a world without leprosy’ or as long as we do not have the tool to achieve that ‘further reducing’ and ‘sustainability’?). The Why will determine in what way and among and with whom knowledge and skill, in relation to leprosy, need to be shared and kept alive and in action.

Is there a forum at which, in relation to maintaining leprosy expertise, the what and where and who and how and when and why is discussed and possibly agreed upon for concerted action?

WHO developed its strategic plan together with partners. Part and parcel of this is the attention to maintaining leprosy expertise and devolving this to PHC and Persons affected by leprosy.  National Governments are in the process of developing their national plans, using the WHO plan as a blueprint and guideline.  There is a community of persons affected who believe they can and should play a role in relation to keep the knowledge and skills alive.

ILEP has developed a strategic plan with commitments like ‘promoting collaboration’, ‘co-operation’, ‘stimulating support’ and ‘monitoring the global leprosy situation and attempting to identify unmet needs’.  Voluntary organisations like TLM and other ILEP members must have strategic plans, either internationally or within the various countries.  Donors are offering opportunities.  Researchers and training and research institutions have their plans and wants.

Do we need to get an overview of all this and identify the strength and weaknesses, the opportunities and risks/threats (a SWOT)?  One threat perceived is the loss of expertise.  What expertise?  Are we talking about leprologists only, (leprosy) researchers?

What and where and who and how and when and why?  What do we know about the present situation and will we able to agree on what to be desired and how to get there? Who is going to monitor and who is going to respond?

Dr Piet Both
The Leprosy Mission Int
Country Development Director

[*]
GLRA = german leprosy relief association
ILEP = international federation of anti leprosy associations
LML = leprosy mailing list
NLR  = netherlands leprosy relief
PHC = primary health care
TLM = the leprosy mission

Tuesday, May 4, 2010

Advert for the position of Chief Executive of LEPRA Health in Action

Leprosy Mailing List – January 31st, 2010

Ref.: Advert for the position of Chief Executive of LEPRA Health in Action (see attachment)

From: Yvonne Jefford, Colchester, Essex , UK


Dear Dr Noto,

I am attaching an advert for the position of Chief Executive of LEPRA Health in Action. This is an important leadership role for LEPRA and we are kindly requesting that details be circulated to the Leprosy Mailing List.

Thank you for your attention.

With best regards,

Yvonne Jefford

Personnel Manager

LEPRA Health in Action,

28 Middleborough , Colchester, Essex , C01 1TG .

Tel: 01206 216700. Fax: 01206 762151

Direct Dial: 01206 216705

Please note that my email address has changed to: YvonneJ(at)leprahealthinaction.org